Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Boshuizen J, Vredevoogd DW, Krijgsman O, Ligtenberg MA, Blankenstein S, de Bruijn B, Frederick DT, Kenski JCN, Parren M, Brüggemann M, Madu MF, Rozeman EA, Song JY, Horlings HM, Blank CU, van Akkooi ACJ, Flaherty KT, Boland GM, Peeper DS. Boshuizen J, et al. Among authors: bruggemann m. Nat Commun. 2020 Aug 7;11(1):3946. doi: 10.1038/s41467-020-17739-8. Nat Commun. 2020. PMID: 32770055 Free PMC article.
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Boshuizen J, Vredevoogd DW, Krijgsman O, Ligtenberg MA, Blankenstein S, de Bruijn B, Frederick DT, Kenski JCN, Parren M, Brüggemann M, Madu MF, Rozeman EA, Song JY, Horlings HM, Blank CU, van Akkooi ACJ, Flaherty KT, Boland GM, Peeper DS. Boshuizen J, et al. Among authors: bruggemann m. Nat Commun. 2023 Feb 7;14(1):672. doi: 10.1038/s41467-023-35852-2. Nat Commun. 2023. PMID: 36750559 Free PMC article. No abstract available.
Detection and imaging of atmospheric radio flashes from cosmic ray air showers.
Falcke H, Apel WD, Badea AF, Bähren L, Bekk K, Bercuci A, Bertaina M, Biermann PL, Blümer J, Bozdog H, Brancus IM, Buitink S, Brüggemann M, Buchholz P, Butcher H, Chiavassa A, Daumiller K, de Bruyn AG, de Vos CM, Di Pierro F, Doll P, Engel R, Gemmeke H, Ghia PL, Glasstetter R, Grupen C, Haungs A, Heck D, Hörandel JR, Horneffer A, Huege T, Kampert KH, Kant GW, Klein U, Kolotaev Y, Koopman Y, Krömer O, Kuijpers J, Lafebre S, Maier G, Mathes HJ, Mayer HJ, Milke J, Mitrica B, Morello C, Navarra G, Nehls S, Nigl A, Obenland R, Oehlschläger J, Ostapchenko S, Over S, Pepping HJ, Petcu M, Petrovic J, Plewnia S, Rebel H, Risse A, Roth M, Schieler H, Schoonderbeek G, Sima O, Stümpert M, Toma G, Trinchero GC, Ulrich H, Valchierotti S, van Buren J, van Cappellen W, Walkowiak W, Weindl A, Wijnholds S, Wochele J, Zabierowski J, Zensus JA, Zimmermann D. Falcke H, et al. Among authors: bruggemann m. Nature. 2005 May 19;435(7040):313-6. doi: 10.1038/nature03614. Nature. 2005. PMID: 15902250 Free article.
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category.
Kotrova M, Fronkova E, Svaton M, Drandi D, Schön F, Hoogeveen P, Hancock J, Skotnicova A, Schilhabel A, Eckert C, Clappier E, Cazzaniga G, Schäfer BW, van Dongen JJM, Ritgen M, Pott C, van der Velden VHJ, Trka J, Brüggemann M. Kotrova M, et al. Among authors: bruggemann m. Leukemia. 2024 May 17. doi: 10.1038/s41375-024-02265-z. Online ahead of print. Leukemia. 2024. PMID: 38760480 No abstract available.
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy of ponatinib versus imatinib in combination with low-intensity chemotherapy, to compare end of therapy with indication for SCT versus TKI, blinatumomab and chemotherapy in optimal responders and to evaluate blinatumomab in suboptimal responders (GMALL-EVOLVE).
Lang F, Pfeifer H, Brüggemann M, Hermann E, Serve H, Goekbuget N. Lang F, et al. Among authors: bruggemann m. Oncol Res Treat. 2024 May 16. doi: 10.1159/000539391. Online ahead of print. Oncol Res Treat. 2024. PMID: 38754400
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Neumann M, Beder T, Bastian L, Hänzelmann S, Bultmann M, Wolgast N, Hartmann A, Trautmann H, Ortiz-Tanchez J, Schlee C, Schroeder M, Fransecky L, Vosberg S, Fiedler W, Alakel N, Heberling L, Kondakci M, Starck M, Schwartz S, Raffel S, Müller-Tidow C, Schneller F, Reichle A, Burmeister T, Greif PA, Brüggemann M, Gökbuget N, Baldus CD. Neumann M, et al. Among authors: bruggemann m. Leukemia. 2024 May 14. doi: 10.1038/s41375-024-02264-0. Online ahead of print. Leukemia. 2024. PMID: 38744920
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
van der Velden VHJ, Dombrink I, Alten J, Cazzaniga G, Clappier E, Drandi D, Eckert C, Fronkova E, Hancock J, Kotrova M, Kraemer R, Montonen M, Pfeifer H, Pott C, Raff T, Trautmann H, Cavé H, Schäfer BW, van Dongen JJM, Trka J, Brüggemann M; EuroMRD Consortium. van der Velden VHJ, et al. Among authors: bruggemann m. Leukemia. 2024 May 14. doi: 10.1038/s41375-024-02272-0. Online ahead of print. Leukemia. 2024. PMID: 38744919
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Fürstenau M, Giza A, Weiss J, Kleinert F, Robrecht S, Franzen F, Stumpf J, Langerbeins P, Al-Sawaf O, Simon F, Fink AM, Schneider C, Tausch E, Schetelig J, Dreger P, Böttcher S, Fischer K, Kreuzer KA, Ritgen M, Schilhabel A, Brüggemann M, Stilgenbauer S, Eichhorst B, Hallek M, Cramer P. Fürstenau M, et al. Among authors: bruggemann m. Blood. 2024 Apr 15:blood.2023022730. doi: 10.1182/blood.2023022730. Online ahead of print. Blood. 2024. PMID: 38620072
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Kroeze E, Iaccarino I, Kleisman MM, Mondal M, Beder T, Khouja M, Höppner MP, Scheijde-Vermeulen MA, Kester LA, Brüggemann M, Baldus CD, Cario G, Bladergroen RS, Garnier N, Attarbaschi A, Verdu-Amorós J, Sutton R, Macintyre EA, Scholten K, Arias Padilla L, Burkhardt B, Beishuizen A, den Boer ML, Kuiper RP, Loeffen JLC, Boer JM, Klapper W. Kroeze E, et al. Among authors: bruggemann m. Blood. 2024 Apr 8:blood.2024023938. doi: 10.1182/blood.2024023938. Online ahead of print. Blood. 2024. PMID: 38588489
283 results